Please login to the form below

Not currently logged in
Email:
Password:

Glyxambi

This page shows the latest Glyxambi news and features for those working in and with pharma, biotech and healthcare.

AZ gets US approval for diabetes combo Qtern

AZ gets US approval for diabetes combo Qtern

It is the second combination of its type to be approved for marketing in the US after Eli Lilly and Boehringer Ingelheim's Glyxambi (linagliptin/empagliflozin). ... At one point the UK group suggested Qtern would become a $3bn product at peak, but the

Latest news

More from news
Approximately 3 fully matching, plus 7 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Novasecta

We are a specialist strategy consulting firm for pharmaceutical and biotech companies. We help our clients to achieve significant performance...

Latest intelligence

Article: Like, Like, Like: Harnessing the power of social media insights
...
Its Know Your Numbers week
Do you know yours?...
What is changing in mental health and dementia care?
Paul Midgley, of Wilmington Healthcare, takes a look at the NHS Long Term Plan's bid to transform mental health and dementia services...

Infographics